These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 15795933)

  • 61. Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatment.
    Vogt L; Laverman GD; van Tol A; Groen AK; Navis G; Dullaart RP
    Nephrol Dial Transplant; 2006 Jan; 21(1):101-6. PubMed ID: 16141462
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Important differences between human and mouse APOE gene promoters: limitation of mouse APOE model in studying Alzheimer's disease.
    Maloney B; Ge YW; Alley GM; Lahiri DK
    J Neurochem; 2007 Nov; 103(3):1237-57. PubMed ID: 17854398
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects.
    Plomgaard P; Dullaart RP; de Vries R; Groen AK; Dahlbäck B; Nielsen LB
    J Intern Med; 2009 Sep; 266(3):258-67. PubMed ID: 19457058
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Decreased beta-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration.
    Noguchi M; Yoshita M; Matsumoto Y; Ono K; Iwasa K; Yamada M
    J Neurol Sci; 2005 Oct; 237(1-2):61-5. PubMed ID: 15992827
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Predominant apolipoprotein J exists as lipid-poor mixtures in cerebrospinal fluid.
    Suzuki T; Tozuka M; Kazuyoshi Y; Sugano M; Nakabayashi T; Okumura N; Hidaka H; Katsuyama T; Higuchi K
    Ann Clin Lab Sci; 2002; 32(4):369-76. PubMed ID: 12458888
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cerebrospinal fluid of Alzheimer patients promotes beta-amyloid fibril formation in vitro.
    Ono K; Noguchi M; Matsumoto Y; Yanase D; Iwasa K; Naiki H; Yamada M
    Neurobiol Dis; 2005 Nov; 20(2):233-40. PubMed ID: 16242632
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.
    Jia JP; Jia JM; Zhou WD; Xu M; Chu CB; Yan X; Sun YX
    Chin Med J (Engl); 2004 Aug; 117(8):1161-4. PubMed ID: 15361288
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Biological markers in cerebrospinal fluid (CSF) and evaluation of in vitro effect of CSF on PC12 cell line viability in Alzheimer's disease.
    Yaka E; Egrilmez MY; Keskinoglu P; Cavdar Z; Genc S; Genc K; Iyilikci L; Yener GG
    Cell Biochem Funct; 2009 Aug; 27(6):395-401. PubMed ID: 19639578
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases.
    Yin GN; Lee HW; Cho JY; Suk K
    Brain Res; 2009 Apr; 1265():158-70. PubMed ID: 19368810
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Blood-brain barrier permeability correlates with medial temporal lobe atrophy but not with amyloid-beta protein transport across the blood-brain barrier in Alzheimer's disease.
    Matsumoto Y; Yanase D; Noguchi-Shinohara M; Ono K; Yoshita M; Yamada M
    Dement Geriatr Cogn Disord; 2007; 23(4):241-5. PubMed ID: 17310121
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease.
    Zetterberg H; Andreasson U; Hansson O; Wu G; Sankaranarayanan S; Andersson ME; Buchhave P; Londos E; Umek RM; Minthon L; Simon AJ; Blennow K
    Arch Neurol; 2008 Aug; 65(8):1102-7. PubMed ID: 18695061
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Vitamin E in neurodegenerative disorders: Alzheimer's disease.
    Kontush K; Schekatolina S
    Ann N Y Acad Sci; 2004 Dec; 1031():249-62. PubMed ID: 15753151
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Influence of Isoforms and Carboxyl-Terminal Truncations on the Capacity of Apolipoprotein E To Associate with and Activate Phospholipid Transfer Protein.
    Dafnis I; Metso J; Zannis VI; Jauhiainen M; Chroni A
    Biochemistry; 2015 Sep; 54(38):5856-66. PubMed ID: 26337529
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of apoE isoforms on beta-amyloid-induced matrix metalloproteinase-9 in rat astrocytes.
    Guo S; Wang S; Kim WJ; Lee SR; Frosch MP; Bacskai BJ; Greenberg SM; Lo EH
    Brain Res; 2006 Sep; 1111(1):222-6. PubMed ID: 16919608
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study.
    Freund-Levi Y; Hjorth E; Lindberg C; Cederholm T; Faxen-Irving G; Vedin I; Palmblad J; Wahlund LO; Schultzberg M; Basun H; Eriksdotter Jönhagen M
    Dement Geriatr Cogn Disord; 2009; 27(5):481-90. PubMed ID: 19439966
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cerebrospinal fluid lipoprotein delivery to human neuronal cells is increased in Alzheimer's disease and is dependent on apoE monomer concentration.
    Bassett CN; Swift LL; Montine KS; Markesbery WR; Montine TJ
    J Alzheimers Dis; 2002 Feb; 4(1):19-30. PubMed ID: 12214015
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease.
    Montine TJ; Markesbery WR; Morrow JD; Roberts LJ
    Ann Neurol; 1998 Sep; 44(3):410-3. PubMed ID: 9749613
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment.
    Ahmed N; Ahmed U; Thornalley PJ; Hager K; Fleischer G; Münch G
    J Neurochem; 2005 Jan; 92(2):255-63. PubMed ID: 15663474
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Concentration of serum amyloid P component in the CSF as a possible marker of cerebral amyloid deposits in Alzheimer's disease.
    Hawkins PN; Rossor MN; Gallimore JR; Miller B; Moore EG; Pepys MB
    Biochem Biophys Res Commun; 1994 Jun; 201(2):722-6. PubMed ID: 7516157
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Oxysterols as biomarkers in neurodegenerative diseases.
    Leoni V; Caccia C
    Chem Phys Lipids; 2011 Sep; 164(6):515-24. PubMed ID: 21515244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.